Yasushi Uemura
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
The role of glial cells missing 2 in induced pluripotent stem cell parathyroid differentiation.
Journal: Tissue & cell
Published: May 31, 2024
Artificial thymic organoid culture generates functional iPSC-derived CD4+ invariant natural killer T cells.
Journal: Communications biology
Published: February 20, 2024
The Induction of Parathyroid Cell Differentiation from Human Induced Pluripotent Stem Cells Promoted Via TGF-α/EGFR Signaling.
Journal: Stem cells and development
Published: August 28, 2023
The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma.
Journal: Translational oncology
Published: February 14, 2023
Future prospects for cancer immunotherapy using induced pluripotent stem cell-derived dendritic cells or macrophages.
Journal: Experimental dermatology
Published: November 17, 2022
Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.
Journal: Cancer letters
Published: January 26, 2022
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells.
Journal: Nature biomedical engineering
Published: December 21, 2021
Analysis of human glioma-associated co-inhibitory immune checkpoints in glioma microenvironment and peripheral blood.
Journal: International journal of immunopathology and pharmacology
Published: December 20, 2021
CD11b+DIP2A+LAG3+ cells facilitate immune dysfunction in colorectal cancer.
Journal: American journal of cancer research
Published: July 29, 2021
Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma.
Journal: International journal of molecular sciences
Published: January 06, 2021
Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha.
Journal: Journal of dermatological science
Published: November 21, 2020
Last Updated: 09/26/2026